# Phase 1 delivery evidence pack

## Artifact identity

| Field | Value |
| --- | --- |
| Project | Ogma Library |
| Deliverable | Phase 1 evidence baseline and scope freeze |
| Owner | Peter Bamuhigire / Chwezi Core Systems |
| Implementer | Principal implementation engineer |
| Reviewer | Owner approval supplied by the 2026-08-20 execution directive; independent technical review `NOT ASSESSED` |
| Date | 2026-08-20 |
| Skills applied | `skills-web-dev`, `srs-skills`; evidence redaction principles from the approved roadmap |

## Decision record

| Decision | Rationale | Alternatives rejected | Reversal trigger |
| --- | --- | --- | --- |
| Freeze exactly 39 desktop phases | It is the latest explicit owner correction and resolves competing plans. | Continue the historical 24-phase plan; add mobile/public-site work. | Owner-approved roadmap revision. |
| Make requirement accountability executable | Counts and assignments otherwise drift silently across DOCX and Markdown. | A prose-only count; duplicating all IDs in another manual register. | Canonical source format changes beyond DOCX/Markdown parsing. |
| Treat stale feature claims as historical | Source existence does not prove current acceptance or physical behavior. | Carry prior “implemented” labels forward. | Current phase evidence satisfies the new DoD. |
| Exclude private content from evidence | Reproducibility does not require disclosure of the user's collection. | Store prompts/passages for convenience. | Explicit privacy-approved synthetic or cleared corpus policy. |

## Contract evidence

| Contract | Evidence | Location | Verdict |
| --- | --- | --- | --- |
| Product/requirement scope | Scope and conflict freeze | `scope-conflict-freeze.md` | PASS |
| Requirement accountability | SRS-to-roadmap executable comparison | `scripts/Test-RequirementAccountability.ps1` | PASS |
| Database baseline | Migration Git tree and assumptions recorded | `evidence-manifest.md` | PASS for baseline; no Phase 1 schema change |
| PDF/search/AI/3D baseline | Version and non-release assumptions recorded | `evidence-manifest.md` | PASS for baseline only |
| Privacy evidence boundary | Four-class handling and explicit exclusions | `scope-conflict-freeze.md` | PASS |

## Test and operational evidence

| Layer | Result |
| --- | --- |
| Unit/integration/API/filesystem | PASS in 637-test core suite |
| Architecture | PASS, 37/37 |
| Accessibility/frontend rendering | PASS automated UI suite, 126/126; physical AT `NOT ASSESSED` |
| Reliability | Complete solution 800/800; LAN 59/59; focused catalogue load 12/12 repeated runs |
| Security | Existing security tests passed; NuGet audit clean; esbuild advisory remediated at 0.28.2; npm audit clean; analyzer and secret scans passed |
| Rollback | Documentation/CI-only change; revert the Phase 1 commit if the freeze is superseded |
| Observability | Evidence IDs, commit, environment, results and unavailable gates recorded |
| Capacity | Reference machines and dataset tiers named; most physical capacity gates remain `NOT ASSESSED` |

## Anti-slop and release verdict

- Every completion claim links to an executable gate or named evidence artifact.
- The initial LAN 500 is disclosed with recurrence results and an assigned watch
  phase; it is not converted into a generic “all tests always passed” claim.
- Platform/provider/signing limitations are explicitly `NOT ASSESSED`.
- No runtime architecture, schema or feature is declared complete in Phase 1.

| Gate | Verdict | Note |
| --- | --- | --- |
| Scope/architecture | PASS | Authority and conflict policy frozen |
| Security/privacy | PASS for evidence handling | Runtime hardening remains assigned to later phases |
| Reliability | PASS for baseline | LAN transient remains a Phase 17 watch item |
| Data | PASS for baseline | Migration hash recorded; no mutation |
| Documentation | PASS | Contributor guidance and execution ledger corrected |
| Independent review | NOT ASSESSED | Owner approval exists; no separate reviewer assigned |

Final Phase 1 decision: **complete the evidence freeze and proceed to Phase 2;
do not claim product release readiness.**
